Clinical Trials Browser

Phase 1/2 × bexmarilimab × Clear all

NCT07460986 2026-03-10

BEXAR

Phase 1/2 Not yet recruiting

Sarcoma

NCT05428969 2026-02-20

BEXMAB

Phase 1/2 Active not recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms

NCT05104905 2022-05-11

RENACOL

Phase 1/2 Withdrawn

GastrointestinalGenitourinary

Carcinoma, Renal Cell, Colonic Neoplasms